Insider Selling: Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Sells 30,156 Shares of Stock

Abrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. sold 30,156 shares of the business's stock in a transaction on Thursday, April 10th. The stock was sold at an average price of $11.14, for a total transaction of $335,937.84. Following the sale, the insider now directly owns 3,094,316 shares in the company, valued at approximately $34,470,680.24. The trade was a 0.97 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Major shareholders that own at least 10% of a company's shares are required to disclose their transactions with the SEC.